Rankings
Pricing
Log In
Free Trial
US-listed companies
VBI Vaccines Inc
VBI Vaccines Inc
VBIV
Market cap
$1.55M
P/E ratio
Add to your list
Add to your list
Back to summarized table
B
M
K
USD
Annual
Quarterly
Download CSV
Income statement
Balance sheet
Cash flow
Dec 31,
2016
Dec 31,
2017
Dec 31,
2018
Dec 31,
2019
Dec 31,
2020
Dec 31,
2021
Dec 31,
2022
NET LOSS
-23
-39
-64
-55
-46
-70
-113
Depreciation and amortization
1
1
1
1
2
2
2
Stock-based compensation
3
2
3
4
5
10
10
Amortization of debt discount
0
1
1
1
2
3
2
Loss on extinguishment of long-term debt
-
-
-
-
-
-
-0
Inventory reserve
-
-
-
-
1
0
1
Unrealized foreign exchange loss (gain)
-
-
-
-
-
-
-27
Change in accounts receivable
-0
-0
-0
0
-0
-0
0
Change in inventory
0
0
0
0
2
1
6
Change in prepaid expenses
-
0
0
-0
1
1
-0
Change in other current assets
-0
0
-0
-0
8
-6
3
Change in other long-term assets
0
0
0
-0
-0
1
0
Change in operating right of use assets
-
-
-
-
-1
-1
-1
Change in accounts payable
0
-1
4
-5
2
0
9
Change in deferred revenues
-
-
5
-2
-1
-0
0
Change in other current liabilities
3
5
4
0
-1
11
-3
Payments made on operating lease liabilities
-
-
-
-
-
-
1
Net cash flows used in operating activities
-19
-31
-46
-49
-47
-40
-74
Purchase of property and equipment
1
1
6
4
1
2
4
Net cash flows used in/ provided by investing activities
2
-1
-6
-4
-26
23
-4
Proceeds from issuance of common shares for in financing transactions
24
72
47
40
122
33
-
Share issuance costs
-
5
3
3
6
1
-
Proceeds from issuance of common shares upon exercise of warrants
-
-
-
-
2
0
-
Proceeds from issuance of common shares upon exercise of stock options
0
0
0
-
0
0
0
Proceeds from debt financing
-
-
-
-
20
12
20
Debt issuance costs
-
-
-
-
1
0
1
Net cash flows provided by financing activities
36
67
44
37
122
44
19
Effect of exchange rates on cash
-
-
-1
-0
0
0
-0
CHANGE IN CASH FOR THE YEAR
-
-
-8
-15
50
28
-59
Interest paid
-
2
2
2
2
2
3
Adjustments for prior periods from adoption of ASU 2020-06
-
-
-
-
-
-
1
Warrant modification in connection with debt amendment
-
-
-
-
-
-1
-
Warrants issued in connection with financing transactions
-
-
-
-
-
-
2
Common shares issued in connection with cashless warrant exercise
-
-
-
-
-
4
-
Capital expenditures included in accounts payable and other current liabilities
-
-
-
-
-
0
0
Share issuance costs included in accounts payable and other current liabilities
-
-
-
-
-0
-0
0